Streetbeat News

Dividends

BOWL

Bowlero has announced the initiation of a quarterly dividend of $0.055. This marks the company's first foray into providing regular dividend payments to its shareholders, signaling a new phase in its financial strategy and potentially increasing its attractiveness to dividend investors.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 2:33 pm

META

Meta Platforms Inc (NASDAQ:META) announced its first-ever dividend of 50 cents per share and a $50 billion share buyback program, following a 25% revenue increase to $40.1 billion in Q4 2023. The company's stock surged 15% after exceeding earnings expectations, marking a significant recovery with a 439% increase since November 2022. This turnaround is attributed to Meta's focus on AI integration and plans for further AI investments in 2024.

Portfolio Pulse from Zaheer Anwari

February 05, 2024 | 2:10 pm

EL

Estee Lauder (NYSE:EL) shares surged premarket after reporting Q2 FY24 results that exceeded expectations, with a sales decline of 7% Y/Y to $4.279 billion, surpassing analyst estimates. The company also announced a quarterly dividend of $0.66 per share and revised its FY24 outlook. Additionally, Estee Lauder is expanding its Profit Recovery Plan, aiming for significant operating profit increases by FY26.

Portfolio Pulse from Lekha Gupta

February 05, 2024 | 1:56 pm

MPW

NSA

UNIT

Wall Street's most accurate analysts recommend selling three high-dividend yielding real estate stocks: Uniti Group Inc. (UNIT), Medical Properties Trust, Inc. (MPW), and National Storage Affiliates Trust (NSA). These recommendations come amidst market turbulence, with each stock facing specific challenges such as weaker-than-expected sales or plans to recover uncollected rents.

Portfolio Pulse from Avi Kapoor

February 05, 2024 | 1:36 pm

LLY

Eli Lilly (NYSE:LLY) is anticipated to release its Q4 earnings on Feb. 6, 2024, with expected earnings of $2.19 per share and revenue of $8.93 billion, up from the previous year. The company is in talks with the German government to lift a ban on weight-loss treatment coverage. Eli Lilly offers a 0.78% annual dividend yield, equating to $1.30 per share quarterly. To earn $500 monthly from dividends, an investment of approximately $770,468 is required. LLY shares rose 1.1% to close at $667.65 recently.

Portfolio Pulse from Avi Kapoor

February 05, 2024 | 1:36 pm

CI

Cigna Corporation (NYSE:CI) reported Q4 2023 sales of $51.15 billion, a 12% increase Y/Y, surpassing consensus estimates. Adjusted EPS was $6.79, beating Wall Street's expectation of $6.53. The company also announced a 14% increase in its quarterly dividend to $1.40 per share and provided a strong FY 2024 revenue outlook of at least $235 billion with an adjusted EPS of at least $28.25. Following the report, Cigna's shares rose 5.4%. Analysts from Cantor Fitzgerald and RBC Capital raised their price targets on Cigna, upgrading the stock to Overweight and Outperform, respectively.

Portfolio Pulse from Avi Kapoor

February 05, 2024 | 1:15 pm

NSSC

Napco Security Technologies announced a quarterly dividend of $0.10/share, payable on March 22, with a record date of March 1. This represents a 25% increase from the previous dividend of $0.08 paid on December 22.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:45 pm

CNA

L

Loews Corp (NYSE:L) shares are trading higher premarket after reporting higher Q4 FY23 earnings and revenues compared to the previous year. Net income increased to $446 million with EPS of $1.99, and revenues rose to $4.26 billion. CNA Financial Corp (NYSE:CNA), a contributor to Loews' revenue, also reported increased revenue and net income. Loews' Boardwalk Pipelines and Loews Hotels segments showed revenue growth, although Loews Hotels experienced a slight decline in net income. Loews also repurchased 2.1 million shares for $141 million during the quarter.

Portfolio Pulse from Lekha Gupta

February 05, 2024 | 12:44 pm

MGY

Magnolia Oil & Gas has announced a 13% increase in its quarterly dividend to $0.13 per share. This move reflects the company's strong financial position and commitment to returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:10 pm

NRXP

NRx Pharmaceuticals announced the creation of Hope Therapeutics to focus on NRX-100 (now HTX-100), aimed at treating suicidal depression. NRx and its shareholders will own the new company, receiving shares as a dividend plus a royalty coupon on HTX-100 sales, pending Board approval. The arrangement is structured to avoid taxation for shareholders.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:52 am